PRMT1 and cancer: In conclusion, our findings shed light on the molecular mechanism by which the Wnt pathway epigenetically regulates T cell polyfunctionality by upregulating PRMT1 and suggest a potential treatment for enhancing immunotherapy against pathogens and cancer in clinical applications.